Uncovering cell-type-specific immunomodulatory variants and molecular phenotypes in COVID-19 using structurally resolved protein networks

Immunomodulatory variants that lead to the loss or gain of specific protein interactions often manifest only as organismal phenotypes in infectious disease. Here, we propose a network-based approach to integrate genetic variation with a structurally resolved human protein interactome network to prioritize immunomodulatory variants in COVID-19. We find that, in addition to variants that pass genome-wide significance thresholds, variants at the interface of specific protein-protein interactions, even though they do not meet genome-wide thresholds, are equally immunomodulatory. The integration of these variants with single-cell epigenomic and transcriptomic data prioritizes myeloid and T cell subsets as the most affected by these variants across both the peripheral blood and the lung compartments. Of particular interest is a common coding variant that disrupts the OAS1-PRMT6 interaction and affects downstream interferon signaling. Critically, our framework is generalizable across infectious disease contexts and can be used to implicate immunomodulatory variants that do not meet genome-wide significance thresholds.

Authors

Institutions

Publication Details

Journal
Cell Reports
Published
2024-11-01
DOI
https://doi.org/10.1016/j.celrep.2024.114930
Citations
2
Primary Topic
Bioinformatics and Genomic Networks
Type
article
Field-Weighted Citation Impact
0.47

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Uncovering cell-type-specific immunomodulatory variants and molecular phenotypes in COVID-19 using structurally resolved protein networks

Reinhard Hinterleitner, Munesh Kumar Harioudh, Prabal Chhibbar, Harinder Singh et al.
2 citations
Cell Reports
Bioinformatics and Genomic Networks
0.47
article

Uncovering cell-type-specific immunomodulatory variants and molecular phenotypes in COVID-19 using structurally resolved protein networks

Reinhard Hinterleitner, Munesh Kumar Harioudh, Prabal Chhibbar, Harinder Singh, Donghui Yang, Saumendra N. Sarkar, Daniel J. McGrail, Nidhi Sahni, S. Stephen Yi, Jishnu Das, Yi‐Nan Gong, P. Roy
article en
2 citations

Abstract

Immunomodulatory variants that lead to the loss or gain of specific protein interactions often manifest only as organismal phenotypes in infectious disease. Here, we propose a network-based approach to integrate genetic variation with a structurally resolved human protein interactome network to prioritize immunomodulatory variants in COVID-19. We find that, in addition to variants that pass genome-wide significance thresholds, variants at the interface of specific protein-protein interactions, even though they do not meet genome-wide thresholds, are equally immunomodulatory. The integration of these variants with single-cell epigenomic and transcriptomic data prioritizes myeloid and T cell subsets as the most affected by these variants across both the peripheral blood and the lung compartments. Of particular interest is a common coding variant that disrupts the OAS1-PRMT6 interaction and affects downstream interferon signaling. Critically, our framework is generalizable across infectious disease contexts and can be used to implicate immunomodulatory variants that do not meet genome-wide significance thresholds.

Cell ReportsVol. 43(11)
Livestrong Foundation (US), Cleveland Clinic (US), The University of Texas MD Anderson Cancer Center (US), University of Pittsburgh (US), Baylor College of Medicine (US), Cleveland Clinic Lerner College of Medicine (US), Quantitative BioSciences (US), The University of Texas at Austin (US)
Cancer Prevention and Research Institute of Texas, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, University of Pittsburgh, National Institutes of Health, National Human Genome Research Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases
Zero hunger
Openalex Percentile: Top 34%
Bioinformatics and Genomic Networks
0.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.